COST-EFFECTIVENESS OF ABATACEPT, RITUXIMAB OR A TNFI AFTER FAILURE OF THE FIRST TNFI TREATMENT IN RA: RESULTS OF A MULTI-CENTERED PRAGMATIC RCT IN THE DREAM REGISTRY

S. Manders; W. Kievit; E. Adang; H. Brus; H. Bernelot Moens; A. Hartkamp; A. Schilder; H. Vonkeman; E. Brouwer; R. Westhovens; H. Visser; M. van de Laar; P. van Riel

doi:10.1136/annrheumdis-2014-eular.3253

COST-EFFECTIVENESS OF ABATACEPT, RITUXIMAB OR A TNFI AFTER FAILURE OF THE FIRST TNFI TREATMENT IN RA: RESULTS OF A MULTI-CENTERED PRAGMATIC RCT IN THE DREAM REGISTRY

S. Manders, W. Kievit, E. Adang, H. Brus, H. Bernelot Moens, A. Hartkamp, A. Schilder, H. Vonkeman, E. Brouwer, R. Westhovens, H. Visser, M. van de Laar, P. van Riel

Research output: Contribution to journal › Meeting Abstract › Academic

Original language	English
Pages (from-to)	684-684
Number of pages	1
Journal	Annals of the Rheumatic Diseases
Volume	73
DOIs	https://doi.org/10.1136/annrheumdis-2014-eular.3253
Publication status	Published - Jun-2014
Event	15th Annual European Congress of Rheumatology (EULAR) - Paris, France Duration: 11-Jun-2014 → 14-Jun-2014

Access to Document

10.1136/annrheumdis-2014-eular.3253

Handle.net

Persistent link

Cite this

Manders, S., Kievit, W., Adang, E., Brus, H., Moens, H. B., Hartkamp, A., Schilder, A., Vonkeman, H., Brouwer, E., Westhovens, R., Visser, H., van de Laar, M., & van Riel, P. (2014). COST-EFFECTIVENESS OF ABATACEPT, RITUXIMAB OR A TNFI AFTER FAILURE OF THE FIRST TNFI TREATMENT IN RA: RESULTS OF A MULTI-CENTERED PRAGMATIC RCT IN THE DREAM REGISTRY. Annals of the Rheumatic Diseases, 73, 684-684. https://doi.org/10.1136/annrheumdis-2014-eular.3253

@article{1052e26cdced4fa6ba9ff25aa585271e,

title = "COST-EFFECTIVENESS OF ABATACEPT, RITUXIMAB OR A TNFI AFTER FAILURE OF THE FIRST TNFI TREATMENT IN RA: RESULTS OF A MULTI-CENTERED PRAGMATIC RCT IN THE DREAM REGISTRY",

author = "S. Manders and W. Kievit and E. Adang and H. Brus and Moens, {H. Bernelot} and A. Hartkamp and A. Schilder and H. Vonkeman and E. Brouwer and R. Westhovens and H. Visser and {van de Laar}, M. and {van Riel}, P.",

year = "2014",

month = jun,

doi = "10.1136/annrheumdis-2014-eular.3253",

language = "English",

volume = "73",

pages = "684--684",

journal = "Annals of the Rheumatic Diseases",

issn = "0003-4967",

publisher = "BMJ Publishing Group",

note = "15th Annual European Congress of Rheumatology (EULAR) ; Conference date: 11-06-2014 Through 14-06-2014",

}

Manders, S, Kievit, W, Adang, E, Brus, H, Moens, HB, Hartkamp, A, Schilder, A, Vonkeman, H, Brouwer, E, Westhovens, R, Visser, H, van de Laar, M & van Riel, P 2014, 'COST-EFFECTIVENESS OF ABATACEPT, RITUXIMAB OR A TNFI AFTER FAILURE OF THE FIRST TNFI TREATMENT IN RA: RESULTS OF A MULTI-CENTERED PRAGMATIC RCT IN THE DREAM REGISTRY', Annals of the Rheumatic Diseases, vol. 73, pp. 684-684. https://doi.org/10.1136/annrheumdis-2014-eular.3253

TY - JOUR

T1 - COST-EFFECTIVENESS OF ABATACEPT, RITUXIMAB OR A TNFI AFTER FAILURE OF THE FIRST TNFI TREATMENT IN RA

T2 - 15th Annual European Congress of Rheumatology (EULAR)

AU - Manders, S.

AU - Kievit, W.

AU - Adang, E.

AU - Brus, H.

AU - Moens, H. Bernelot

AU - Hartkamp, A.

AU - Schilder, A.

AU - Vonkeman, H.

AU - Brouwer, E.

AU - Westhovens, R.

AU - Visser, H.

AU - van de Laar, M.

AU - van Riel, P.

PY - 2014/6

Y1 - 2014/6

U2 - 10.1136/annrheumdis-2014-eular.3253

DO - 10.1136/annrheumdis-2014-eular.3253

M3 - Meeting Abstract

SN - 0003-4967

VL - 73

SP - 684

EP - 684

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

Y2 - 11 June 2014 through 14 June 2014

ER -